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Gerd D€oring, Professor of Medical Microbiology and
Hygiene at the University of T€ubingen (Germany), was
very much looking forward to attending the 14th Interna-
tional Conference on Pseudomonas, to which he had
been invited and where he was going to chair a session
on cystic fibrosis (CF) and lead a discussion on antibiotic
therapy against Pseudomonas aeruginosa infections, in
September 2013. But fate had it otherwise. Gerd died on
2 July 2013, after a malignant melanoma had spread to
his lung with uncanny speed.
Gerd D€oring was born in N€urnberg on 30 August
1948, and studied chemistry at the University of T€ubin-
gen, where he obtained a PhD for his work on transition
metal complexes in 1978. From 1977 to his death, Gerd
mostly worked at the Hygiene Institute in T€ubingen, only
interrupted by scientific visits to Niels Høiby’s laboratory
in Copenhagen in the 1980s and 1990s and by a study
leave in Lyon in 1992. Under the guidance of the former
director of the Hygiene Institute, Konrad Botzenhart,
Gerd D€oring developed a keen interest in P. aeruginosa
and in the chronic infections that this bacterium causes
in the lung of CF patients. His post doctoral ‘habilitation’
thesis published in 1986 dealt with pathogenic
mechanisms of P. aeruginosa (in particular, proteases),
their regulation, and consequences for inflammation.
In the same year, one of us (DH) met Gerd for the
first time at a symposium that he organized on ‘Basic
research and clinical aspects of P. aeruginosa’ in T€ubin-
gen. At that time, Gerd was intrigued by observations
indicating that P. aeruginosa must be well adapted to
hypoxic conditions, in particular in the CF lung, and so
we decided to test whether the ability of P. aeruginosa to
obtain ATP from arginine by fermentation via the Arc-
DABC pathway (thus without respiration) would confer
an advantage on the bacterium when it colonizes host tis-
sues. He quickly did these colonization tests in the rat
lung and intestine and, while it appeared that a mutant
deleted for the arcDABC operon had a lower colonization
ability compared with the wild type, the effects measured
were not significant and therefore not published. How-
ever, Gerd remained convinced that P. aeruginosa was a
successful pathogen in the CF lung because of its ability
to deal with hypoxic conditions. He eventually managed
to assemble compelling evidence for the fact that the
mucus layer in the CF lung becomes depleted of
measurable oxygen and nevertheless supports persistent
growth of P. aeruginosa (Worlitzsch et al. J Clin Invest
109: 317–325, 2002). This important work has been cited
more than 500 times and has led to further important
discoveries, but has also been misinterpreted by some
researchers who believed that P. aeruginosa would adopt
a purely anaerobic lifestyle (i.e. using nitrate respiration
and fermentation) in the CF lung. However, the main
energy source of P. aeruginosa in this environment is still
aerobic respiration, which occurs via the two cbb3
terminal oxidases whose high affinity for oxygen allows
the bacterium to grow at submicromolar oxygen concen-
trations. Such low oxygen levels are undetectable with a
Clark electrode.
In more recent studies, Gerd and his collaborators
found that the so-called mucoid conversion of P. aerugin-
osa is strongly stimulated by oxygen depletion. Mucoidy is
due to overproduction of the exopolysaccharide alginate
by P. aeruginosa and is a hallmark of persistent infection.
It turns out that alginate export is controlled by a novel
oxygen sensor acting at a post-translational level. As
experiments on this mechanism are still ongoing, Gerd
was not able to see their completion and publication,
which saddened him a great deal. But he stayed optimistic
and passionate about this work up to his last days.
Gerd was always keen to translate his research into the
diagnosis, prevention, and treatment of infections with
P. aeruginosa, particularly the chronic airways infections
in individuals with CF. Gerd developed hygienic measures
and devices to control the spread of P. aeruginosa in the
hospital environment, and he and Christiane Wolz, his
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PhD student at that time, were the first in the late 1980s
who demonstrated the nosocomial transmission between
unrelated CF patients at rehabilitation centers with a
molecular probe. Based on his early discovery made in
Niels Høiby’s laboratory that in serial CF sera, antibody
titers against secreted virulence effectors are inversely cor-
related with the clinical outcome, he commercialized an
ELISA that still is the standard for Pseudomonas serology
at central European CF centers. Gerd was involved in the
first clinical trial on aerosolized tobramycin to eradicate
P. aeruginosa from CF patients’ lungs during the early
phase of infection. Virtually as a one-man show, he
conducted phase II and phase III studies on the efficacy
of a P. aeruginosa flagella vaccine and lately he strongly
pursued the concept of using nitric oxide (NO) inhala-
tion therapy in CF patients, to help disperse P. aeruginosa
biofilms in the lung.
Gerd D€oring was the President of the European Cystic
Fibrosis Society from 1998 to 2006, and thereafter until
his death, the Editor-in-Chief of the Journal of Cystic
Fibrosis. During these fifteen years, Gerd organized
European Consensus Conferences that resulted in
guidelines for the early intervention and prevention of
lung disease, clinical trials, and the management of
nutrition and infections. The first consensus paper was
published in 2000 on the antibiotic therapy against
P. aeruginosa in CF.
Gerd D€oring was a very creative and inspiring scientist
with a distinct sense of humor and a knack for
nonconformity, which did not always facilitate his own
academic career in Germany, but greatly helped him with
international networking. Many of his publications are
the fruit of international collaborations that he initiated.
In discussions, Gerd could reach high-flying objectives
and conclusions, often leaving his own ground staff
puzzled. But when he was grounded again, with his
hard-working attitude, he got do-able things done and
this is amply reflected by his list of over 200 scientific
publications. Apart from science, the company of Gerd
was always enjoyable as he was fond of good wines and
food, classical music, and his vintage car, a Citro€en 15 fa-
miliale, which he used on special occasions.
Gerd was sorry that he had to leave so early – his wife
Cornelia, his two sons, his friends, and his work and
projects – but found comfort in looking back on a life
well spent and on a scientific oeuvre fully recognized by
his peers.
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